1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight NOVEMBER 2016

Drug Delivery Insight NOVEMBER 2016

  • November 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Future Of Drug Delivery Lies In Connectivity
Industry Trend Analysis - Mast Therapeutics To Benefit From Philips Agreement
Industry Brief - Intellipharmaceutics Enters Agreement With Mallinckrodt
Industry Brief - Sunovion Completes Acquisition Of Cynapsus Therapeutics
Industry Brief - Synaffix/ADC Enter Commercial Licensing Deal For Antibody-Drug Conjugate Technologies
Industry Brief - Molex Completes Phillips-Medisize Takeover
Industry Trend Analysis - MannKind's Outlook Boosted By Debt Pardon
Industry Trend Analysis - Optimised Portfolio Will Drive Growth
Industry Brief - Collegium Submits sNDA To FDA For Xtampza ER
Industry Brief - Health Canada Approves Narcan Nasal Spray To Treat Opioid Overdose
Industry Brief - FDA Approves Unique Low Dosage Of Zubsolv
Industry Brief - FDA Approves Updated Label/Modified REMS For Adasuve
Industry Brief - FDA Accepts NDA Resubmission Of Sunovion's SUN-101/eFlow For COPD
Industry Trend Analysis - EpiPen Settlement Will Lead To Wider Industry Investigation
Industry Brief - AstraZeneca To Divest Rhinocort Aqua Rights Outside US
Industry Brief - Innovation Zed Introduces InsulCheck Connect To Improve Diabetes Management
Industry Brief - Lucentis PFS Granted FDA Approval
Industry Brief - FDA Misses PDUFA Date For Arymo ER
Industry Brief - Aequus Files CTA For Transdermal Aripiprazole Patch
Industry Brief - UroGen/Allergan Conclude Licensing Deal For RTGel Delivery System
Industry Brief - MiniMed 630G System With SmartGuard Technology Granted Canadian Licence
Industry Brief - Amneal Launches Oestradiol Generic
Industry Brief - Cimzia AutoClicks Prefilled Pen Now Available On NHS
Industry Brief - Daiichi Sankyo/Inspirion Enter US Licensing Deal For MorphaBond
Industry Brief - Intec Granted Chinese Patent For Accordion Pill Carbidopa/Levodopa
Industry Brief - FDA Grants Clearance To Propeller Platform For Use With GSK's Ellipta Inhaler
Industry Brief - BD Launches Syringe Designed For Use With Humulin R U-500
Industry Trend Analysis - Aggressive Oncology Drive Will Secure Takeda Increased Market Share
Industry Brief - Bespak Enters Syrina Auto-Injector Master Development Agreement
Industry Brief - Lupin Enters Paediatric Product Agreement With MonoSol
Industry Brief - SOTIO/NBE To Co-Develop Next-Generation ADCs For Cancer Therapy
Industry Brief - Immunomedics Secures US Patents For ADC And Cancer Immunotherapy Vaccines
Industry Brief - AstraZeneca To Terminate INXAS Phase IIa AZD9412 Trial
Industry Brief - FDA Places Inovio's VGX-3100 Phase III Trial On Clinical Hold
Industry Brief - Braeburn/Camurus Expand Collaboration To Include Buprenorphine Combination Products
Industry Brief - Nordic Nanovector And Heidelberg Pharma Enter Collaboration To Target Leukaemia
Industry Brief - Open-Label Extension Trial Initiated For Zynerba's ZYN002 CBD Gel
Industry Brief - BD Enters Type I Diabetes Research Collaboration
Industry Brief - Drug Delivery Conferences - November 2016

Table Of Contents

Drug Delivery Insight NOVEMBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.